Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 3
1948 1
1949 3
1950 1
1951 4
1952 1
1954 1
1955 3
1957 2
1958 2
1959 2
1960 3
1962 4
1963 6
1964 2
1965 7
1966 2
1967 1
1968 2
1969 2
1970 6
1971 4
1972 2
1973 8
1974 13
1975 5
1976 9
1977 1
1978 3
1979 14
1980 14
1981 7
1982 17
1983 11
1984 12
1985 22
1986 26
1987 19
1988 26
1989 25
1990 18
1991 14
1992 21
1993 22
1994 15
1995 9
1996 27
1997 19
1998 16
1999 20
2000 29
2001 15
2002 5
2003 7
2004 9
2005 11
2006 7
2007 9
2008 6
2009 6
2010 7
2011 10
2012 10
2013 11
2014 13
2015 10
2016 7
2017 3
2018 7
2019 12
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

662 results
Results by year
Filters applied: . Clear all
Page 1
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Xue M, et al. Diabetes 2016 - Clinical Trial. Among authors: Fowler M. PMID 27207552 Free article.
In highly overweight subjects (BMI >27.5 kg/m(2)), tRES-HESP coformulation increased expression and activity of Glo1 (27%, P < 0.05) and decreased plasma methylglyoxal (-37%, P < 0.05) and total body methylglyoxal-protein glycation (-14%, P < 0.01). It decreased fasting and postprandial plasma glucose (-5%, P < 0.01, and -8%, P < 0.03, respectively), increased oral glucose insulin sensitivity index (42 mL ⋅ min(-1) ⋅ m(-2), P < 0.02), and improved arterial dilatation Δbrachial artery flow-mediated dilatation/Δdilation response to glyceryl nitrate (95% CI 0.13-2.11). ...
In highly overweight subjects (BMI >27.5 kg/m(2)), tRES-HESP coformulation increased expression and activity of Glo1 (27%, P < …
662 results
Jump to page
Feedback